We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BATT icon
10251
CALL
Amplify Lithium & Battery Technology ETF
BATT
$125M
$181K ﹤0.01%
14,100
-2,200
-13% -$28.4K
PCYO icon
10252
CALL
Pure Cycle
PCYO
$272M
$181K ﹤0.01%
19,200
+5,900
+44% +$54.4K
SHCR
10253
CALL
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$181K ﹤0.01%
127,700
+95,500
+297% +$216K
AOUT icon
10254
American Outdoor Brands
AOUT
$152M
$181K ﹤0.01%
18,424
-118,890
-87% -$1.19M
IPSC icon
10255
Century Therapeutics
IPSC
$353M
$181K ﹤0.01%
52,200
-78,958
-60% -$347K
VXRT
10256
CALL
DELISTED
Vaxart
VXRT
$181K ﹤0.01%
239,300
-240,000
-50% -$223K
RMR icon
10257
CALL
The RMR Group
RMR
$348M
$181K ﹤0.01%
+6,900
New +$193K
BFAM icon
10258
Bright Horizons
BFAM
$3.7B
$181K ﹤0.01%
+2,350
New +$181K
CLSK icon
10259
CALL
CleanSpark
CLSK
$3.18B
$181K ﹤0.01%
65,000
-222,400
-77% -$610K
CTLP
10260
CALL
DELISTED
Cantaloupe
CTLP
$181K ﹤0.01%
31,700
-17,000
-35% -$90.6K
NNOX icon
10261
PUT
Nano X Imaging
NNOX
$69.4M
$181K ﹤0.01%
31,300
-53,600
-63% -$410K
BYRN icon
10262
Byrna Technologies
BYRN
$90.3M
$181K ﹤0.01%
23,792
+15,076
+173% +$134K
HE icon
10263
PUT
Hawaiian Electric Industries
HE
$2.04B
$180K ﹤0.01%
4,700
+3,400
+262% +$138K
NVT icon
10264
PUT
nVent Electric
NVT
$28.7B
$180K ﹤0.01%
4,200
+2,300
+121% +$97K
EDU icon
10265
New Oriental
EDU
$8.47B
$180K ﹤0.01%
4,671
-118,371
-96% -$4.78M
AHT
10266
Ashford Hospitality Trust
AHT
$20.8M
$180K ﹤0.01%
5,616
-18,471
-77% -$925K
PEBO icon
10267
CALL
Peoples Bancorp
PEBO
$1.48B
$180K ﹤0.01%
7,000
-3,300
-32% -$95K
BLKB icon
10268
CALL
Blackbaud
BLKB
$1.97B
$180K ﹤0.01%
2,600
-1,300
-33% -$77.9K
RNGR icon
10269
Ranger Energy Services
RNGR
$413M
$180K ﹤0.01%
17,679
-1,862
-10% -$20.3K
ENLV icon
10270
Enlivex Ltd
ENLV
$26.6M
$180K ﹤0.01%
3,298
-671
-17% -$40.4K
MYE icon
10271
CALL
Myers Industries
MYE
$1.24B
$180K ﹤0.01%
8,400
+2,100
+33% +$47.8K
RDNW
10272
CALL
RideNow Group
RDNW
$239M
$180K ﹤0.01%
29,700
-13,000
-30% -$106K
RVMD icon
10273
PUT
Revolution Medicines
RVMD
$45.4B
$180K ﹤0.01%
8,300
+3,000
+57% +$73.9K
CTIC
10274
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$180K ﹤0.01%
42,800
+10,800
+34% +$56.1K
DRRX
10275
CALL
DELISTED
DURECT Corp
DRRX
$179K ﹤0.01%
39,600
+10,160
+35% +$55.2K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.